Regenerative Biologic Therapy Disclosure & Patient Information

Regenerative biologic injections at ReGen Now use umbilical‑cord–derived, non‑cellular biologic products containing growth factors, cytokines, and other naturally occurring signaling molecules. These products do not contain live stem cells.

Procedure Details This therapy involves injecting biologic material into the joint or soft‑tissue area. The biologic is intended to support the body’s natural repair processes. Treatment plans vary based on individual circumstances, and responses may differ.

Risks and Possible Side Effects Potential risks include temporary soreness, swelling, bruising, stiffness, or discomfort at the injection site. Less common risks include infection, allergic reaction, or lack of improvement.

Benefits Some individuals report improved mobility, reduced discomfort, or enhanced joint function. Experiences vary and depend on individual factors.

Experimental / Off‑Label Use Disclosure Umbilical‑cord–derived biologics used in this therapy are considered experimental and off‑label. They are not FDA‑approved for the treatment of any specific medical condition.

Alternative Treatment Options Other options may include physical therapy, medications, corticosteroid injections, hyaluronic acid injections, platelet‑rich plasma (PRP), lifestyle modification, or surgical evaluation.

Outcome and Limitation Disclosure Results vary. No specific outcome can be predicted or guaranteed. Some individuals may experience improvement, while others may experience minimal or no change.

Documentation and Consent A detailed informed‑consent document describing the procedure, risks, benefits, alternatives, and limitations is reviewed with each patient. Signed consent is retained in the patient’s medical record.